12-17岁青少年实验室确诊COVID-19住院特征分析
基于COVID-NET监测网络,分析2020年3月1日至2021年4月24日14个州12-17岁青少年COVID-19相关住院情况。2021年1-3月204例主要因COVID-19住院的青少年中,31.4%入住ICU,4.9%需有创机械通气,无死亡。2020年10月至2021年4月累积住院率是近期三个流感季的2.5-3.0倍。
要点
- 青少年COVID-19住院可致重症:31.4%入ICU,4.9%需有创机械通气。
- 2020年10月至2021年4月累积住院率是流感季的2.5-3.0倍。
- 2021年3-4月住院率回升,提示需持续预防措施包括疫苗接种。
核心结论
- 青少年COVID-19相关住院可导致严重疾病,且累积住院率高于近期流感季。
研究设计与样本
- 基于COVID-NET监测网络,分析14个州2020年3月1日至2021年4月24日12-17岁青少年COVID-19相关住院数据。
- 重点分析2021年1月1日至3月31日204例主要因COVID-19住院的青少年的人口学和临床特征。
主要发现
- 2021年1月1日至3月31日204例住院青少年中,31.4%入住ICU,4.9%需有创机械通气,无相关死亡。
- 2020年3月1日至2021年4月24日,每周青少年住院率在2021年1月初峰值达2.1/10万,3月中旬降至0.6,4月升至1.3。
- 2020年10月1日至2021年4月24日累积COVID-19住院率是2017-18、2018-19和2019-20三个流感季流感相关住院率的2.5-3.0倍。
临床怎么用
- 青少年COVID-19可导致重症,应继续采取预防措施,包括疫苗接种和未完全接种者正确佩戴口罩。
- 监测数据显示青少年住院率高于流感季,支持扩大疫苗接种年龄范围至12-15岁。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Most COVID-19-associated hospitalizations occur in older adults, but severe disease that requires hospitalization occurs in all age groups, including adolescents aged 12-17 years (1). On May 10, 2021, the Food and Drug Administration expanded the Emergency Use Authorization for Pfizer-BioNTech COVID-19 vaccine to include persons aged 12-15 years, and CDC's Advisory Committee on Immunization Practices recommended it for this age group on May 12, 2021.* Before that time, COVID-19 vaccines had been available only to persons aged ≥16 years. Understanding and describing the epidemiology of COVID-19-associated hospitalizations in adolescents and comparing it with adolescent hospitalizations associated with other vaccine-preventable respiratory viruses, such as influenza, offers evidence of the benefits of expanding the recommended age range for vaccination and provides a baseline and context from which to assess vaccination impact. Using the Coronavirus Disease 2019-Associated Hospitalization Surveillance Network (COVID-NET), CDC examined COVID-19-associated hospitalizations among adolescents aged 12-17 years, including demographic and clinical characteristics of adolescents admitted during January 1-March 31, 2021, and hospitalization rates (hospitalizations per 100,000 persons) among adolescents during March 1, 2020-April 24, 2021. Among 204 adolescents who were likely hospitalized primarily for COVID-19 during January 1-March 31, 2021, 31.4% were admitted to an intensive care unit (ICU), and 4.9% required invasive mechanical ventilation; there were no associated deaths. During March 1, 2020-April 24, 2021, weekly adolescent hospitalization rates peaked at 2.1 per 100,000 in early January 2021, declined to 0.6 in mid-March, and then rose to 1.3 in April. Cumulative COVID-19-associated hospitalization rates during October 1, 2020-April 24, 2021, were 2.5-3.0 times higher than were influenza-associated hospitalization rates from three recent influenza seasons (2017-18, 2018-19, and 2019-20) obtained from the Influenza Hospitalization Surveillance Network (FluSurv-NET). Recent increased COVID-19-associated hospitalization rates in March and April 2021 and the potential for severe disease in adolescents reinforce the importance of continued COVID-19 prevention measures, including vaccination and correct and consistent wearing of masks by persons not yet fully vaccinated or when required by laws, rules, or regulations.†.
引用
- Havers FP, Whitaker M, Self JL, et al. Hospitalization of Adolescents Aged 12-17 Years with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 1, 2020-April 24, 2021. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34111061. doi:10.15585/mmwr.mm7023e1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。